Cascade Chemistry Plans for Expansion of cGMP Pharmaceutical Manufacturing Capacity

Specifications:

Name:

Cascade Chemistry Plans for Expansion of cGMP Pharmaceutical Manufacturing Capacity

Location:

Eugene, Oregon

Company:

Cascade Chemistry

Estimated Cost:

$14 Million

Source:

https://cascadechemistry.com/

Introduction:

Cascade Chemistry invests $14 million for construction of new facilities designed to increase the company’s capacity to manufacture APIs (active pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures).

Features:

The new facilities, expected to be operational in the first quarter of 2022, will ultimately increase the company’s floor space almost three-fold and significantly add to its cGMP manufacturing capacity and scale. The expansion also includes 2,200 square feet of new analytical labs, a robust quality system and additional office space.

The 28,000-square-foot building currently under construction will initially include five suites for Phase 1 and Phase 2 cGMP manufacturing with flow hydrogenation and reactors up to 400 liters. Additional capacity for API Phase 3 and commercial scale cGMP manufacturing up to 1,000 liters will be added in 2022. The second building, with 7,000 square feet, is reserved for future expansion.